Genome-wide association studies (GWASs) have identified multiple common genetic variants associated with an increased risk of testicular germ cell tumors (TGCTs). A previous GWAS reported a possible TGCT susceptibility locus on chromosome 1q23 in the UCK2 gene, but failed to reach genome-wide significance following replication. We interrogated this region by conducting a meta-analysis of two independent GWASs including a total of 940 TGCT cases and 1559 controls for 122 single-nucleotide polymorphisms † The authors contributed jointly to this work. (SNPs) on chromosome 1q23 and followed up the most significant SNPs in an additional 2202 TGCT cases and 2386 controls from four case -control studies. We observed genome-wide significant associations for several UCK2 markers, the most significant of which was for rs3790665 (P Combined 5 6.0 3 10 29 ). Additional support is provided from an independent familial study of TGCT where a significant over-transmission for rs3790665 with TGCT risk was observed (P FBAT 5 2.3 3 10 23 ). Here, we provide substantial evidence for the association between UCK2 genetic variation and TGCT risk.
INTRODUCTION
In most developed countries, testicular germ cell tumors (TGCTs) are the most common cancers among men between the ages of 15 and 40 years and incidence rates have been increasing for .50 years (1) . The highest rates in the world occur in Norway (12.1/100 000) and Denmark (10.3/100 000) (2) . Regardless of the overall incidence in a specific country, however, TGCT incidence is four to five times higher in men of European ancestry than in men of Asian or African ancestry (3) . Exogenous risk factors for TGCTs are not yet well elucidated. It is known, however, that risk is increased among men born with undescended testes (4) . In addition, men who have had a prior diagnosis of subfertility or TGCT, or who have a family history of TGCT, are at increased risk (5) .
The risk of TGCT has been reported to be 8-to 10-fold higher in brothers and 2-to 4-fold higher in sons of men who have had TGCT (6 -10) . Familial studies have estimated that genetic effects account for nearly a quarter of TGCT risk, which is one of the largest estimated heritabilities reported for any type of cancer (11) . Despite the high heritability of TGCT, linkage and candidate gene studies have had limited success identifying TGCT susceptibility loci (12) (13) (14) (15) (16) (17) (18) (19) . More recently, genome-wide association studies (GWASs) have implicated multiple genomic regions associated with TGCT risk, including those containing KITLG, SPRY4, BAK1, ATF7IP, DMRT1 and TERT (20) (21) (22) (23) . The discriminative power for TGCT risk using the seven independent GWAS loci plus a rare deletion on the Y chromosome is 69.2% (24) , suggesting that additional loci remain undiscovered. Rapley et al. (22) reported a possible TGCT susceptibility locus on chromosome 1. However, the single-nucleotide polymorphism (SNP) rs4657482, which resides within the gene UCK2 on chromosome band 1q23, failed to reach genome-wide significance following replication (P GWAS ¼ 1.6 × 10
26
; P Replication ¼ 0.07; P Combined ¼ 2.0 × 10
). Here, we present the results from a meta-analysis of the UCK2 region from two GWASs of TGCT with additional independent replication that, in turn, have established SNP markers in UCK2 exceeding the threshold for genome-wide significance.
RESULTS
To identify susceptibility loci for TGCTs, we conducted a meta-analysis of the GWASs at the National Cancer Institute (NCI) and the University of Southern California (USC). Replication was implemented in studies conducted at the University of Washington (ATLAS study), Oslo University Hospital-Radium Hospital (OUHRH study), MD Anderson Cancer Center (MDA study) and the University of Pennsylvania (TestPAC study) (Table 1 and Supplementary Material, Notes). Further validation of the top UCK2 associations was conducted in a USC TGCT familial study independent of the USC GWAS. In total, the UCK2 meta-analysis included 122 overlapping SNPs in the NCI and USC GWAS among 2499 cases and controls (Table 1 ). For each of these studies, a 1df trend test for association with TGCT was performed for the 122 UCK2 SNPs assessed in both studies (Supplementary Material, Tables S1 and S2). The combined association tests were generated using a fixed-effects meta-analysis (see the Methods section) and are presented in Supplementary Material, Table S3 for the entire UCK2 region.
In the combined meta-analysis, six SNPs were identified with the corresponding P-values ,5.0 × 10
25
, including the previously reported UCK2 marker rs4657482 (P GWAS ¼ 2.25 × 10
27
; Supplementary Material, Table S3 ) (22) . Five of the top six SNPs were selected for further replication analysis in four additional case -control studies totaling 2202 cases and 2386 controls ( Table 2) . Two of the studies, the ATLAS study and the TestPAC study, used the iPLEX mass array genotyping platform. The OUHRH study and the MDA study conducted optimized TaqMan genotyping. The pair-wise linkage disequilibrium (LD) for the five SNPs among NCI controls (n ¼ 1056) showed high LD, except for the SNP rs12562047 (Supplementary Material, Table S4 ), which is located within an inferred recombination hotspot interval ( Fig. 1 ; chr1:164,090,507-164,097,507). Three of the replication markers (rs12562047, rs4657482 and rs6703280) are located in the first intron of the UCK2 gene. Two of the markers (rs3790665 and rs3790672) are within introns closer to the 3 ′ region of the gene ( Fig. 1) , within an interval defined by two recombination peaks identified by five tests of 100 NCI controls without resampling using SequenceLDhot program (25) .
We observed that four of the five tested SNP markers were associated with TGCTs at the level of genome-wide significance (P , 5.0 × 10
28
; Table 2 ). In the combined analysis, the most significant association was observed for rs3790665 (P Combined ¼ 6.0 × 10
29
) with a summary odds ratio (OR) estimate of 1.26 (95% confidence interval, CI, 1.17-1.37) per copy of the C allele (Supplementary Material, Fig. S1 ). The effects were similar across all of the studies (P het ¼ 0.03), except for one study where a null signal was observed. By examining these results in an independent family study, we observed a significant over-transmission (P FBAT ¼ 2.3 × 10 23 ) to the TGCT cases for the rs3790665 risk allele, C (Supplementary Material, Table S5 ).
The second most significant finding from the combined analysis was for SNP rs4657482 (P Combined ¼ 1.2 × 10 28 ), the marker originally reported by Rapley et al. (22) . The combined OR estimate from the meta-analysis for this SNP was 1.25 (95% CI 1.16 -1.35) per copy of the A allele. The corresponding estimates reported by Rapley et al. were 1.39 and 1.14 for their GWAS and replication studies, respectively (22) . We also observed a significant over-transmission of the A allele to TGCT cases in the family study (P FBAT ¼ 5.9 × 10 23 ; Supplementary Material, Table S5 ). The associations reported by Rapley et al. (22) are independent of the associations presented here. A meta-analysis of rs4657482 across our combined association analysis and the combined association reported by Rapley et al. (22) Table S6 ). Although there is a weak correlation between rs12562047 and our strongest signal, rs3790665 (r 2 ¼ 0.18), the former maps within an inferred hotspot and the conditional analysis does not support a second signal. Haplotype analysis for these five markers using HapMap (v3, release 27) CEU/ TSI data estimates the haplotype frequency in which the effect allele (G) for rs12562047 resides with two or more risk alleles for the remaining UCK2 markers is only 3.2%. The estimated haplotype for the referent allele (T) for rs12562047 and two or more risk alleles was 30.5%. Further sequence and fine-mapping analysis is required to define the underlying haplotype, as each of these SNPs reported herein most likely represent markers and not the directly associated variant.
In Supplementary Material, Table S7 , we report the combined meta-analysis results for the known TGCT susceptibility loci in the NCI and USC GWAS. Single or multiple markers reached genome-wide significance for all of the known regions, except the ATF7IP gene region (P ¼ 0.065). Of the significant loci, markers in the KITLG region were the most significant (P ¼
DISCUSSION
In a multi-stage analysis of SNPs in the UCK2 region of chromosome 1, we confirm a TGCT susceptibility locus at 1q23, which harbors the plausible candidate gene uridine/cytidine kinase-2. A marker in this region was previously implicated in TGCT but failed to reach genome-wide significance (22) . We provide here further support for this locus by confirming associations of the most significantly associated variants in an independent family-based study. The most promising SNP, rs3790665, lies in the intronic region of UCK2 near the 3 ′ end of the gene (Fig. 1) . UCK2, initially identified as a testis-specific gene TSA903 (26) , encodes a pyrimidine ribonucleoside kinase that catalyzes the phosphorylation of uridine and cytidine to form uridine monophosphate and cytidine monophosphate (27) Table S8 ). Although further work is necessary to provide a biological basis for the link between UCK2 and TGCT etiology, pharmacological studies have identified UCK2 as responsible for the phosphorylation and activation of a ribonucleoside anticancer drug 3 ′ -ethynyl nucleoside (TAS106). Activity is reportedly higher in tumor cells than in non-tumor cells, influencing accumulation of the drug and resulting in radio-sensitization mediated by suppressed expression of BRCA2 (31, 32) .
These results illustrate the value of combined analyses of genotype data to identify susceptibility loci for rare cancers and the use of family-based studies for validating suspected loci. The locus reported here had been previously suggested for TGCT susceptibility, but remained unconfirmed until this larger meta-analysis was conducted. We have demonstrated that the UCK2 locus on chromosome 1q23 is involved in TGCT susceptibility by identifying highly correlated markers associated with disease at genome-wide levels of statistical significance. As a next step, fine-mapping studies are needed to nominate the optimal markers for functional followup analysis. Laboratory studies will be needed to isolate the functional marker or markers and elucidate the underlying mechanism responsible for the direct association with TGCT risk.
MATERIALS AND METHODS

Samples
The discovery meta-analysis for the UCK2 region (Chr 1: 163,801,412-164,192,158) was conducted using two GWAS datasets, NCI and USC (Table 1 ). In total 122 SNPs overlapped the two GWAS spanning the UCK2 region on chromosome 1. Analyses were based on the datasets following standard quality control procedures (Supplementary Material, Notes). We chose five of the six most significant SNPs in our UCK2 meta-analysis for independent replication. The replication stage included 2202 cases and 2386 controls from four TGCT case-control studies (Table 1 and Supplementary Material, Notes). An independent set of TGCT pedigrees had been enrolled at USC by identifying TGCT probands and recruitment of eligible family members. All studies were limited to non-Hispanic whites and approved by the appropriate ethics committees.
Genotyping
Two replication studies (OUHRH and MDA) and the family studies were genotyped using the 5 ′ -exonuclease assay (Taqman TM ) and the ABI Prism 7900HT sequence detection system, all according to the manufacturer's instructions, across several genotyping centers. Primers and probes were supplied directly by Applied Biosystems as Assays-By-Design TM . The ATLAS and TestPAC studies conducted genotyping using the iPLEX mass array platform. Assays at all genotyping centers included at least four negative controls and 2-5% duplicates on each 384-well plate. Data on each SNP for a given site had to fulfill the following to be included: SNP call rate .95%, no deviation from Hardy-Weinberg equilibrium in controls at P , 0.00001; ,2% discordance between genotypes in duplicate. Cluster plots for SNPs that were close to failing any of the QC criteria were re-examined centrally.
Statistical methods
Each GWAS assessed genetic associations using a 1df trend test assuming an additive genetic inheritance model adjusting for population ancestry, age and study using PLINK for the USC GWAS and GLU (Genotyping Library and Utilities; http://code.google.com/p/glu-genetics/) for the NCI GWAS. ORs and 95% CIs were estimated using unconditional logistic regression. Replication case -control studies were analyzed using unconditional logistic regression. A fixed-effect meta-analysis was performed weighting each study contribution by the inverse of the standard error. A conservative genome-wide level of statistical significance (P , 5.0 × 10
28
) was applied for the combined association analysis to minimize the chance of false-positive results. Within the USC TGCT familial study, a family-based association was tested comparing the distribution of alleles transmitted to affected individuals with the distribution of those alleles that are not transmitted. The over-transmission and undertransmission of each locus were assessed for the replication SNPs. The analytical software FBAT (33) was used for the familial testing.
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Supplementary Material is available at HMG online.
Conflict of Interest statement. None declared.
FUNDING
